Association of the CYP19 gene polymorphism with genetic susceptibility to endometriosis

Chinese Journal of Medical Genetics

Volumn 27, Issue 6, 2010, Pages 692-696

  Yang, Xin ^a   Chen, Su Qin ^a   Liu, Meng ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

CYP19 gene; Endometriosis; Estrogen metabolizing gene; Polymerase chain reaction restriction fragment length polymorphism

Indexed keywords

AROMATASE;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AROMATASE; CASE-CONTROL STUDIES; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC;

EID: 78650946200     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-9406.2010.06.021     Document Type: Article

References (12)

1. Kitawaki J, Kado N, Ishihara H, et al. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol, 2003,83:149-155.
2. Bischoff F, Simpson JL. Genetic basis of endometriosis. Ann N Y Acad Sci, 2004,1034:284-299.
3. Somner J, McLellan S, Cheung J, at al. Polymorphisms in the P450 c17 (17-hydroxylase/17, 20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women. J Clin Endocrinol Metab, 2004,89:344-351. (Pubitemid 38183902)
4. Haiman CA, Hankinson SE, Spiegelman D, et al. No association between a single nucleotide polymorphism in CYP19 and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 2002,11:215-216.
5. Rhiem K, Klein A, Munch M, et al. Chromosomal region 15q21.1 is a frequent target of allelic in advanced breast carcinomas. Int J Cancer, 2003,106:74-77. (Pubitemid 36750390)
6. Dawling S, Roodi N, Parl FF, et al. Hoxyest rogens exert feed back inhibition on cytochrome P4501A1 and 1B1. Cancer Res, 2003,63:3127-3132.
7. Miyoshi Y, Iwao K, Ikeda N, et al. Breast cancer risk associated with polymorphism in CYP19 in Japanese women. Int I Cancer, 2000,89:325-328. (Pubitemid 30620284)
8. Hur SE, Lee S, Lee JY, et al. Polymorphisms and haplotypes of the gene encoding the estrogen-metabolizing CYP19 gene in Korean women: no association with advanced-stage endometriosis. J Hum Genet, 2007,52:703-711.
9. Hirose K, Matsuo K, Toyama T, et al. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese. Cancer Epidemiol Biomarkers Prev, 2004,13:1407-1411.
10. Siegelmann-Danieli N, Buetow KH. Constitutional genetic variation at the human aromatase gene (CYP19) and breast cancer risk. Br T Cancer, 1999,79:456-463.
11. Sourdaine P, Parker MG, Telford J, at al. Analysis of the aromatase cytochrome P450 gene in human breast cancers. J Mol Endocrinol, 1994,13:331-337. (Pubitemid 24380339)
12. Travis RC, Churchman M, Edwards SA, et al. No association of polymorphisms in CYP17, CYP19, and HSD17-B1 with plasma estradiol concentrations in 1,090 British women. Cancer Epidemiol Biomarkers Prev, 2004,13:2282-2284.